David M Chao Centessa Pharmaceuticals PLC (CNTA) insider trading activity

David M Chao is Chief Administrative Officer of Centessa Pharmaceuticals plc. Currently has a direct ownership of 225,007 shares of CNTA, which is worth approximately $2.69 Million. The most recent transaction as insider was on Mar 17, 2025, when has been sold 7,000 shares (Ordinary Shares) at a price of $17.29 per share, resulting in proceeds of $121,030. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 225K

6.96% 3M change

17.58% 12M change

Total Value Held $2.69 Million

DAVID M CHAO Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 17 2025	SELL Open market or private sale	$121,030 $17.29 p/Share	7,000 Reduced 3.02%	225,007 Ordinary Shares
Mar 17 2025	BUY Exercise of conversion of derivative security	$13,475 $3.85 p/Share	3,500 Added 1.49%	232,007 Ordinary Shares
Feb 01 2025	SELL Payment of exercise price or tax liability	$225,442 $16.92 p/Share	13,324 Reduced 5.51%	228,507 Ordinary Shares
Dec 31 2024	SELL Payment of exercise price or tax liability	$169,794 $16.35 p/Share	10,385 Reduced 4.12%	241,831 Ordinary Shares
Sep 30 2024	SELL Payment of exercise price or tax liability	$163,979 $15.79 p/Share	10,385 Reduced 3.95%	252,216 Ordinary Shares
Jun 30 2024	SELL Payment of exercise price or tax liability	$93,776 $9.03 p/Share	10,385 Reduced 3.8%	262,601 Ordinary Shares
Mar 31 2024	SELL Payment of exercise price or tax liability	$117,350 $11.3 p/Share	10,385 Reduced 3.66%	272,986 Ordinary Shares
Feb 01 2024	SELL Payment of exercise price or tax liability	$77,829 $8.19 p/Share	9,503 Reduced 3.24%	283,371 Ordinary Shares
Feb 01 2024	BUY Grant, award, or other acquisition	-	37,500 Added 11.35%	292,874 Ordinary Shares
Dec 31 2023	SELL Payment of exercise price or tax liability	$82,935 $7.96 p/Share	10,419 Reduced 3.92%	255,374 Ordinary Shares
Sep 30 2023	SELL Payment of exercise price or tax liability	$67,410 $6.47 p/Share	10,419 Reduced 3.77%	265,793 Ordinary Shares
Jun 30 2023	SELL Payment of exercise price or tax liability	$61,472 $5.9 p/Share	10,419 Reduced 3.63%	276,212 Ordinary Shares
Mar 31 2023	SELL Payment of exercise price or tax liability	$27,179 $3.9 p/Share	6,969 Reduced 2.37%	286,631 Ordinary Shares
Feb 01 2023	BUY Grant, award, or other acquisition	-	77,200 Added 20.82%	293,600 Ordinary Shares
Dec 31 2022	SELL Payment of exercise price or tax liability	$15,155 $3.1 p/Share	4,889 Reduced 2.12%	225,611 Ordinary Shares
Oct 03 2022	SELL Open market or private sale	$16,460 $3.95 p/Share	4,167 Reduced 1.83%	222,932 Ordinary Shares
Sep 30 2022	SELL Payment of exercise price or tax liability	$39,146 $4.25 p/Share	9,211 Reduced 4.0%	221,289 Ordinary Shares
Sep 30 2022	SELL Open market or private sale	$13,842 $4.07 p/Share	3,401 Reduced 1.48%	227,099 Ordinary Shares
Jul 01 2022	BUY Grant, award, or other acquisition	-	230,000 Added 49.95%	230,500 Ordinary Shares
Jun 02 2021	BUY Open market or private purchase	$10,000 $20.0 p/Share	500 Added 50.0%	500 Ordinary Shares

DMC

David M Chao

Chief Administrative Officer

Cheshire, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNTA shares.

Notify only if

Value

Insider Trading

Get notified when an Centessa Pharmaceuticals PLC insider buys or sells CNTA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Centessa Pharmaceuticals plc

Track Activities on CNTA

Account